Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03761108 · RECRUITING
Trial details
- NCT number
- NCT03761108
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-23
- Primary completion
- 2033-03-30
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.